戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y of bleeding, is characterized by prolonged thrombin time, abnormal fibrin polymerization, and incre
2    Among 68 patients with an elevated dilute thrombin time and 81 with an elevated ecarin clotting ti
3 late (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were re
4  to exosite II of thrombin, prolong both the thrombin time and the activated partial thromboplastin t
5 mes, bilirubin, ammonia levels, prothrombin, thrombin time, and cytokines.
6                                         In a thrombin time assay using purified components, high conc
7                          Reversal of diluted thrombin time (dTT), ecarin clotting time (ECT), activat
8                     For dabigatran, a normal thrombin time excludes clinically relevant drug concentr
9  a monoclonal IgG to exosite II prolongs the thrombin time indirectly by accelerating the thrombin-an
10 f purified VN to VN -/- plasma prolonged the thrombin time into the normal range, suggesting that VN
11 brinogen conversion to fibrin as assessed by thrombin time measurements, and thrombin exosite binding
12            Purified fibrinogen prolonged the thrombin time of normal plasma.
13                                          The thrombin time of plasma or purified fibrinogen was prolo
14                                              Thrombin times of plasma from VN -/- mice (20.5 +/- 2.1
15 of idarucizumab, on the basis of the diluted thrombin time or ecarin clotting time.
16 nation at a central laboratory of the dilute thrombin time or ecarin clotting time.
17  to 100), on the basis of either the diluted thrombin time or the ecarin clotting time.
18 of the commonly used tests, such as PT, PTT, thrombin time, platelet count, fibrinogen, and the prese
19                                   The dilute thrombin time (R(2) = 0.92 to 0.99) and ecarin-based ass
20 cofactor II confirm that prolongation of the thrombin time requires antithrombin.
21 ated partial thromboplastin time (aPTT), and thrombin time (TT) were secondary endpoints assessed by
22 ram/mL), prolongation of the prothrombin and thrombin times was observed.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。